Search By

Format
Articles (121)Events (28)News (1540)Interviews (79)
Publication Date
Last 3 months Last 6 months Last 12 months All Time

1,540 Results

Search By

ArticlesEventsNewsInterviews

Alithea Genomics Signs Deal with Revvity to Scale Transcriptomic Profiling for Drug Discovery

Alithea Genomics and Revvity partner to distribute MERCURIUS DRUG-seq, bringing scalable transcriptomic profiling into mainstream drug discovery screening.

Simantini Singh Deo | Jun 16, 2026

India's Bioeconomy Reaches $190 Billion After 20-Fold Growth Over 12 Years

India's bioeconomy has grown 20-fold to $190 billion in 12 years, with indigenous CAR-T therapy signalling upgraded GMP manufacturing capability.

Simantini Singh Deo | Jun 16, 2026

Sanofi's Tzield Gains FDA Accelerated Approval for Pediatric Stage 3 Type 1 Diabetes on C-Peptide Surrogate Endpoint

FDA grants accelerated approval to Tzield for pediatric Stage 3 T1D using C-peptide surrogate endpoint; boxed warning updated for viral reactivation.

Simantini Singh Deo | Jun 16, 2026

FDA Tightens Scrutiny of OTC Eye Drop Manufacturers Following Contamination-Linked Recalls

FDA's risk-based inspection framework is actively targeting ophthalmic manufacturers following a 2023–2024 contamination recall wave affecting multiple OTC eye drop brands.

Simantini Singh Deo | Jun 16, 2026

Taro Pharmaceutical Launches AB-Rated Lamotrigine ODT Generics Across Four Strengths

Taro Pharmaceutical launches AB-rated Lamotrigine ODT generics in 25, 50, 100, and 200 mg, enabling formulary substitution for Lamictal ODT.

Simantini Singh Deo | Jun 16, 2026

Confo Therapeutics Achieves Preclinical Milestone for CFTX-2034 in Post-Bariatric Hypoglycemia Program

Confo Therapeutics presents CFTX-2034 preclinical data at ENDO 2026, advancing its SSTR5 antibody toward IND-enabling studies for post-bariatric hypoglycemia.

Simantini Singh Deo | Jun 16, 2026

FDA Convenes Workshop on Pediatric Antihypertensive Development, Targeting Evidence Gaps for Under-Six Population

FDA's July 2026 workshop targets evidence gaps in pediatric antihypertensive development, with focus on extrapolation strategies for children under six.

Simantini Singh Deo | Jun 16, 2026